Literature DB >> 7921985

Characterization of lymphocyte subpopulations in cord blood.

C Rabian-Herzog1, S Lesage, E Gluckman, D Charron.   

Abstract

Twenty-seven cord blood samples from healthy newborns were processed according to a "whole blood" flow cytometric analysis. The CD3-positive T cells were a variable subpopulation representing 44.8 +/- 13.3% of lymphocytes. The majority of the CD3+ cells are CD38+. Newborn T cells have lower levels of both IL-2 receptors and HLA-DR than do adult T cells. The CD4-positive T cells represented 31.0 +/- 10.8% of lymphocytes with a great prevalence of the CD4+/CD45RA+ population. The CD3+/CD8+/CD11b+ cells are increased to 23.4 +/- 7.1% of lymphocytes. The CD57 antigen is not expressed. The NK population, CD16+/CD56+, is increased to 25 +/- 11% of lymphocytes. Of CD19+ cord blood B lymphocytes 68% coexpressed CD5. Thus "suppressive" and "naive" cells are prominently represented in cord blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7921985     DOI: 10.1089/scd.1.1993.2.255

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  4 in total

Review 1.  Umbilical cord blood transplantation.

Authors:  A M Will
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

2.  Evaluation of various methods of maternal placental blood collection for immunology studies.

Authors:  Caroline Othoro; Julie M Moore; Kathleen Wannemuehler; Bernard L Nahlen; Juliana Otieno; Laurence Slutsker; Altaf A Lal; Ya Ping Shi
Journal:  Clin Vaccine Immunol       Date:  2006-05

3.  Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia.

Authors:  R N Pahwa; A Fleischer; S Than; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

4.  Fetal natural killer cell function is suppressed.

Authors:  E Dominguez; J A Madrigal; Z Layrisse; S B Cohen
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.